PCM
MANE

Penserra Capital Management’s Veradermics Inc MANE Stock Holding History

Penserra Capital Management’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,700
Closed -$928K – 1213
2026
Q1 		$928K Buy
+14,700
New +$742K 0.01% 479

Other funds holding MANE

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Penserra Capital Management's MANE Position: Q2 2026 in Review

Penserra Capital Management sold out of Veradermics Inc (MANE) in Q2 2026, closing a stake of 14,700 shares — an estimated $928K sold.

Penserra Capital Management first reported a position in MANE in Q1 2026 and held it in 1 quarter. The position peaked at $928K in Q1 2026. 164 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Penserra Capital Management reported no remaining Veradermics Inc position as of Q2 2026 after selling out during the quarter.
  • Penserra Capital Management sold 14,700 Veradermics Inc shares in Q2 2026, an estimated $928K.
  • Penserra Capital Management first reported a position in Veradermics Inc in Q1 2026 and held it in 1 quarter.
  • Penserra Capital Management's Veradermics Inc position peaked at $928K in Q1 2026.
  • 164 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.